Market Overview

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)

109.86 +0.75 (0.69%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/19/19BarclaysUpgradesOverweight132.0
8/05/19BarclaysMaintainsEqual-Weight110.0
6/11/19BarclaysInitiates Coverage OnEqual-Weight131.0
9/19/18H.C. WainwrightMaintainsBuy270.0
8/17/18Goldman SachsInitiates Coverage OnNeutral256.0
8/08/18Roth CapitalDowngradesNeutral
6/21/18ArgusInitiates Coverage OnBuy260.0
3/07/18H.C. WainwrightMaintainsBuy182.0
1/24/18H.C. WainwrightMaintainsBuy170.0
11/20/17Deutsche BankDowngradesSell

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter